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ABSTRACT 
World Health Organization introduced standard treatment guidelines 
for a killer disease of pregnant women worldwide, Preeclampsia, are 
compared with current practices in the tertiary care centers. 
Magnesium sulphate and delivery is the treatment of choice for pre-
eclampsia. Implementation of STGs in the tertiary care centers of 
Islamabad that is Federal Government Services Hospital, Pakistan 
Institute of Medical Sciences and Shifa international Hospital are 
assessed. Furthermore the prescribing practice of Islamabad (three 
hospitals) sector is compared with such of the Abbottabad (Ayub 
Medical Complex), for pre-eclampsiac women. Knowledge of 
physicians in gynecology department at Islamabad and Abbottabad are 
assessed. In the tertiary care centers of Islamabad 45% patients are 
receiving magnesium sulphate as recommended by WHO 5% cases are   
delivery which is also standard way of treatment during preeclampsia. In Abbottabad sector 
93% patients are receiving magnesium sulphate and 4% are delivery cases. The variation 
from WHO guidelines is least in Ayub Medical complex Abbottabad. This small researchon 
200 patients also depicts the individual tertiary care center reports for STGs in pre-
eclampsiac women. The knowledge of physician changes where a question occurs that their 
course of study do not contain précised WHO recognized book. There are some mind 
blowing facts inside this report. As a result I proudly say that our health sector is not very far 
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away from standards proposed by World Health Organization for a better healthy 
environment. 
 
KEYWORDS: WHO Stgs, Pre Eclampsia, Eclampsia, Prenatal Care, Magnesium Sulphate, 
Delivery Risks. 
 
INTRODUCTION 
Pre-eclampsia 
Common Killer of Pregnant Women Worldwide 
(Also known as toxemia and Pregnancy-Induced High Blood Pressure) consists of high 
blood pressure, protein in the urine and edema (swelling). It can rapidly become severe pre-
eclampsia, with very high blood pressure, visual disturbances, failing kidneys and elevated 
liver enzymes. In rare cases, pre-eclampsia develops into eclampsia, where potentially fatal 
convulsions occur. It also can become HELLP Syndrome (hemolysis (H), which is the 
breaking down of red blood cells, elevated liver enzymes (EL), and low platelet count (LP), 
which is potentially fatal to both the woman and her baby or babies 
 
In this project keen efforts are made to assess the implementation of standard treatment 
guidelines proposed by WHO for pre-eclampsia women having no other ailment. Based on 
the latest scientific evidence, the World Health Organization (WHO) has recommended 
magnesium sulfate as the most effective, safe, and low-cost anticonvulsant medication to treat 
eclampsia and pre-eclampsia. 
 
STATEMENT OF PROBLEM  
If I list the statement of problems this would be very clear from the literature mentioned in 
the report that there is less or no research work on Standard Treatment Guidelines of pre-
eclampsia in Asia and most importantly in Pakistan. We can find studies regarding diagnosis 
and even about treatment of pre-eclampsia but to assess the criterion of STGs prescription is 
the first project in Pakistan till now. This is very necessary keep ourselves in the line of 
standards introduces to avoid the mortality rate. Second problem might be of data collection 
as there are most pre-eclampsia cases those remain undiagnosed due to illiteracy. As for s this 
project is concerned this was to conduct in tertiary care centers of two developed cities of 
Pakistan so I am hopeful that there are; least chances of undiagnosed patients. 
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LITERATURE REVIEW 
Preeclampsia is a very serious condition that affects seven to 10% of all pregnancies in the 
United States. This percentage is proposed by an author K. Bridget Brosnihan, a professor at 
Wake Forest University School of Medicine's Hypertension and Vascular Research Center. 
He further said in a news release. "It can be devastating to both mother and baby, and 
currently there is no cure except to deliver the fetus” (Namen et at., 2001). 
 
A 1998 review concluded that it is effective in preventing convulsions in women who have 
severe pre-eclampsia and in stopping convulsions in eclamptic women. The review consisted 
of 19 randomized, controlled trials, five retrospective studies and eight observational reports 
published in English between 1966 and February 1998. The review also concluded that more 
research is needed on whether magnesium sulfate is effective for women with mild pre-
eclampsia and gestational high blood pressure (Witlin & Sabai, 1998; Heyborne, 2007). 
 
Magnesium sulphate is the drug of choice in pre-eclampsia. In the United States, it has been 
used to treat severe pre-eclampsia for 60 years and is FDA-approved for this purpose 
(Rengan, et al., 2012). 
 
The staff from MAYO Clinic says that the only cure for pre-eclampsia is delivery. You are at 
increased risk of seizures, placental abruption, stroke and possibly severe bleeding until your 
blood pressure decreases. Of course, if it's too early in your pregnancy, delivery may not be 
the best thing for your baby. If you've had pre-eclampsia in one or more previous 
pregnancies, some experts recommend more frequent prenatal visits than normally 
recommended for pregnancy. Your doctor may ask you to come in every two weeks between 
the 20th and 32nd week of your gestation, and weekly after that until delivery. They further 
says that magnesium sulphate should be given for treating seizures, if you have severe pre-
eclampsia or HELLP syndrome, corticosteroid medications can temporarily improve liver 
and platelet functioning to help prolong your pregnancy and antihypertensive medicines are 
given to lower blood pressure. Corticosteroids can also help your baby's lungs become more 
mature in as little as 48 hours — an important step in helping a premature baby prepares for 
life outside the womb (Harms et al,. 2013). 
 
A research was conducted in 2008 in which again magnesium sulphate was considered as 
first important drug in pre-eclampsia to be considered. The goal of this research is to develop 
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a system of care that avoids overdose and facilitates the use of magnesium sulfate for the 
treatment of pre-eclampsia (Gangooly et al., 2014). 
 
Another organized health center proposed that Delivery of the baby is the only way to cure 
pre-eclampsia. If pre-eclampsia develops when it is too early to deliver your baby, you may 
be put on bed rest. Depending on your specific situation and severity of the preeclampsia, bed 
rest may be ordered at home or in the hospital (Keller et al., 2008).  
 
In the handbook of sign and symptoms third edition 2006 magnesium sulphate is advised as 
ked medicine in pre-eclampsia (Mecham, 2006). 
 
Another study was conducted by Dr. Nadia from King Edward Medical University and she 
focused on mid-wife care. She says to prescribe specialist-led care or to exclude general 
practitioner (GP) or midwife led care. It is recognized that all women benefit from a 
continuity of care and need midwifery care as part of their individual antenatal care plan, 
whatever their obstetric risk (Joseph et al.,2003). 
 
In 2007 Engender Health and the University of Oxford conducted the research in which they 
explained that use of magnesium sulphate in pre-eclampsia and eclampsia is beneficial and 
what hurdles discourages that use! 
 
This historic gathering of global public health experts identified the primary barriers to the 
use of magnesium sulfate: lack of national guidelines, shortage of educated and trained health 
care professionals, and scarce supplies of magnesium sulfate. They also admitted the WHO 
words that Epsom salt is safest and effective in above mentioned ailments (Hussein et 
al.,2011).  
 
In MAGPIE study 2000 it is said clearly that in some cases, women with preeclampsia or 
eclampsia can be stabilized temporarily with magnesium sulfate intravenously to forestall 
seizures while steroid injections are administered to promote fetal lung maturation. 
Magnesium sulfate as a possible treatment was considered at least as far back as 1955, but 
only in recent years did its use in the UK replace the use of diazepam or phenytoin.  Study 
showed that magnesium sulphate is best when induced delivery needs to take place before 37 
weeks gestation, it is accepted that there are additional risks to the baby from premature birth 
that will require additional monitoring and care. 
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Aspirin supplementation is still being evaluated as to dosage, timing, and population and may 
provide a slight preventative benefit in some women; however, significant research has been 
done on aspirin and the results thus far are unimpressive (Figueiredo et al,. 2009). 
 
Recent research by the Medical Research Council (MRC) has shown that giving magnesium 
sulphate injections to pregnant women with pre-eclampsia halves their risk of developing 
eclampsia. New research suggests that the antioxidants contained in vitamin C, vitamin E, 
selenium, and lycopene can reduce the chance of pregnant women developing pre-eclampsia. 
Research into treatments of pre-eclampsia is ongoing (Fisk et al.,2009).  
 
The treatment available for PE is to stabilize the patient and terminate the pregnancy 
(Muffley et al.,2002).  
 
SIGNIFICANCE OF STUDY 
This project would be a great addition in the previous studies made on STGs of pre-eclampsia 
internationally as this is first study of its type in Pakistan. Studies are there for prevalence, 
pathophysiology, treatment, diagnosis and way of dose administration of pre-eclampsia but to 
compare prescriptions prescribed by doctors with the standard treatment guidelines was a 
study felt to be conducted. In this way the level of qualification and practice method of 
physician is also assumed. Similarly a pharmacist is also involved in the study as I am also 
comparing the dose of STG given by World Health Organization. So directly or indirectly 
physician, pharmacist and patient is involved. 
 
Furthermore the study will be an excellent help for all four tertiary centers to modify and 
monitor their prescriptions. This will involve the better work of physician and pharmacist and 
a better health care system of pre-eclampsiac women. 
 
BACKGROUND  
Preeclampsia is a disorder that occurs only during pregnancy and the postpartum period and 
affects both the mother and the unborn baby. Affecting at least 5-8% of all pregnancies, it is a 
rapidly progressive condition characterized by high blood pressure and the presence of 
protein in the urine. Swelling, sudden weight gain, headaches and changes in vision are 
important symptoms; however, some women with rapidly advancing disease report few 
symptoms.  
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Globally, preeclampsia and other hypertensive disorders of pregnancy are a leading cause of 
maternal and infant illness and death. By conservative estimates, these disorders are 
responsible for 76,000 maternal and 500,000 infant deaths each year (Wambach et al., 2014).  
 
ECLAMPSIA 
Eclampsia, an acute and life-threatening complication of pregnancy, is characterized by the 
appearance of tonic-clonic seizures, usually in a patient who had developed preeclampsia. 
(Preeclampsia and eclampsia are collectively called Hypertensive disorder of pregnancy and 
toxemia of pregnancy). 
 
Eclampsia excludes seizures and coma that happen during pregnancy but are due to 
preexisting or organic brain disorders (Program, 2000). 
 
ANTENATAL CARE 
The regular antenatal visits are designed to increase in frequency in later pregnancy. This 
increase is in order to assess the likely ability of the baby to be delivered vaginally and to 
assess the growth and development of the baby; but of equal importance, the blood pressure 
and urine are screened for preeclampsia.  
 
If the blood pressure is increased at any time before the delivery, then women may be 
requested to have more frequent blood pressure readings. They might be asked to visit a day 
stay unit where the blood pressures are taken for a few hours (rather than a one off reading) 
and the baby is assessed.  
 
If increased blood pressure alone develops, some units may start tablets to lower the blood 
pressure (or at least prevent further rises in blood pressure). If other features of preeclampsia 
occur, such as headaches or liver pain, then admission to hospital is likely to be required in a 
multidisciplinary Centre such as a major teaching hospital. It is likely that blood pressure 
specialists will be involved early in the decision about the use of tablets and the possible 
timing of the delivery.  
 
OBJECTIVES 
 I plan to conduct a comparative study among the tertiary health care centers of Islamabad 
sector to have a brief review of criterion of implementation of standard treatment guidelines 
of preeclampsia in women.  
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 I am also determined to have renounced comparison between three tertiary health  care 
centers, in Islamabad  and  with one such center in Abbottabad;Ayub Medical Hospital. 
 
MAIN OBJECTIVES OF THE STUDY 
1.To make a comparison of standard treatment of pre-eclampsia with the current practice in 
the tertiary health centers of Islamabad. 
2.To compare current practice of treatment of preeclampsia in Islamabad & one tertiary care 
center in Abbottabad 
3.Percentage of qualified staff in hospitals.  
4.Knowledge of medical person in pre-eclampsia. 
 
RATIONALE 
 Helping, develop and/or reinforce world’s international protocols mandatory for 
preeclampsia. 
 Ensuring awareness among the people will increase even during the survey session when 
i will meat such patients in the tertiary health centers. 
 I will be able to find deviation from standard treatment; if any. 
 This project firstly depicts the difference of treatment in basic health unit of capital city to 
one of the basic health unit in Abbottabad city. 
 A clear idea from the death rate will give the importance of research work required in this 
ailment. Also it may alert the ministry to put an eye towards such tertiary facilities. 
 Definitely a step towards prevention. 
 
FEATURES 
 Simple and easy to understand project about the world’s killing disease in women. 
 Depicts a clear cut way to step forward for the filling of gaps. 
 Interview and questionnaire creates awareness among the local people. 
 
METHODOLOGY 
TYPE OF STUDY 
 Cross-sectional comparative study. 
 
STUDY SETTING 
 Tertiary care centers of Islamabad, and Abbottabad Pakistan. 
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DATA RESPONDENT 
 Pregnant women and physician. 
 
SAMPLE SIZE 
 100 prescriptions. 
 100 questionnaire filled by physician. 
 
SAMPLE STRATEGY 
 Convenience sampling technique. 
 
DATA ANALYSIS TOOL 
 SPSS VERSION 17.0 
 
VARIABLES 
 Knowledge of doctors about standard treatment 
 Gestational age of the patient 
 Age of the patient 
 Magnesium sulphate present as standard 
 Nifidipine in the prescription 
 Aldomet in the prescription 
 Normal saline through IV in prescription 
 Dexomethasone present in prescription 
 Frusemide present in prescription 
 ISDN present in prescription 
 Methyl dopa present in prescription 
 Aspirin present in prescription 
 Captopril present in prescription 
 Iron sulphate present in prescription 
 Multivitamin present in prescription 
 
INDICATORS 
1. %age of prescriptions containing MgSO4 only. 
2. %age of prescriptions containing calcium gluconate  only 
3. %age of prescriptions containing calcium gluconate + magnesium sulphate. 
4. %age of prescriptions containing Dihydralazine  only 
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5. %age of prescriptions containing calcium gluconate + magnesium sulphate + 
Dihydralazine. 
6. %age of prescriptions containing some new drugs. 
7. %age of delivery or abortion cases. 
 
RESULTS 
FREQUENCIES FOR ISLAMABAD DATA (THROUGH SPSS 17) 
 
Table 1: Frequencies for Islamabad Data 
 
Age of patient 
at ISB 
Gestational age 
of patient at ISB 
Magnesium 
sulphate prescribed 
or delivery advised 
at ISB 
Methyl dopa 
prescribed at 
ISB 
Nifidipine 
prescribed 
at ISB 
Frusemide 
prescribed at 
ISB 
Missing 0 0 0 0 0 0 
Valid 100 100 100 100 100 100 
 
ISDN 
prescribed at 
ISB 
Captopril 
prescribed at 
ISB 
Amino infusion 
prescribed at ISB 
Steroids 
prescribed at 
ISB 
Aspirin 
prescribed 
at ISB 
Iron sulphate 
prescribed at 
ISB to pre-
eclampsiac 
Missing 0 0 0 0 0 0 
Valid 100 100 100 100 100 100 
 
Vitamin B12 or 
folic acid or 
normal saline 
prescribed at 
ISB to pre-
eclampsiac 
What is STG for 
pre-eclampsia 
by WHO in ISB 
    
Missing 0 0     
Valid 100 100     
A sample of 100 was taken from Islamabad for each variable including the prescription 
sample for standard drug advice check. Physician knowledge assessment includes 
questionnaires as tools. 
www.wjpps.com                                Vol 4, Issue 08, 2015.                                            
            
 
1575 
Shahbaz.                                       World Journal of Pharmacy and Pharmaceutical Sciences 
Table 2: Age of patient at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
18 1 1.0 1.0 1.0 
20 5 5.0 5.0 6.0 
21 2 2.0 2.0 8.0 
22 1 1.0 1.0 9.0 
23 3 3.0 3.0 12.0 
24 4 4.0 4.0 16.0 
25 13 13.0 13.0 29.0 
26 7 7.0 7.0 36.0 
27 3 3.0 3.0 39.0 
28 9 9.0 9.0 48.0 
29 3 3.0 3.0 51.0 
30 11 11.0 11.0 62.0 
31 4 4.0 4.0 66.0 
32 11 11.0 11.0 77.0 
34 4 4.0 4.0 81.0 
35 7 7.0 7.0 88.0 
36 3 3.0 3.0 91.0 
38 1 1.0 1.0 92.0 
39 4 4.0 4.0 96.0 
40 4 4.0 4.0 100.0 
Total 100 100.0 100.0  
The age frequency chart from Islamabad shows that most pre-eclampsia pregnant women are 
from the age group of 25years -30years. The age group highly suffering is 25years of age 
with 13% cases found. 
 
Table 3: Gestational age of patient at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
2 12 12.0 12.0 12.0 
3 88 88.0 88.0 100.0 
Total 100 100.0 100.0  
According to the Islamabad data the gestational age in which pre-eclampsia occurs 88% is 3
rd
 
trimester which is according to the standard studies. As pre-eclampsia occurs mostly in 32
nd
 
week of the pregnancy. (11)          
         
Table 4: Magnesium sulphate prescribed or delivery advised at ISB         
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
STG absent 55 55.0 55.0 55.0 
magnesium 
sulphate present 
40 40.0 40.0 95.0 
Delivery 5 5.0 5.0 100.0 
Total 100 100.0 100.0  
This data from Islamabad clearly depicts that the WHO recommended standard for pre-
eclampsia is present in only 40% of prescriptions. In 55% prescriptions it is absent. On the 
other hand 5% are the delivery cases in pre-eclampsia which is more ideal as treatment as 
proposed by studies. (4) 
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Table 5: Methyl dopa prescribed at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 12 12.0 12.0 12.0 
Present 88 88.0 88.0 100.0 
Total 100 100.0 100.0  
The trend of prescribing methyl dopa is 88% which is more than MgSO4. The clear deviation 
from standard can be observed from the table. Hence methyl dopa is one of the blood 
pressure lowering medicines given in pregnancy. 
 
Table 6: Nifidipine prescribed at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 48 48.0 48.0 48.0 
Present 52 52.0 52.0 100.0 
Total 100 100.0 100.0  
 
Nifidipine is present in 52 % of prescriptions which is again more than MgSO4. 
 
Table 7: Frusemide prescribed at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 71 71.0 71.0 71.0 
Present 29 29.0 29.0 100.0 
Total 100 100.0 100.0  
 
71% of prescriptions do not contain furosemides. Which shows that trend of prescribing this 
medicine during pre-eclampsia in Islamabad is only 29%. 
 
Table 8: ISDN prescribed at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 83 83.0 83.0 83.0 
Present 17 17.0 17.0 100.0 
Total 100 100.0 100.0  
At Islamabad only 17% of prescriptions for pre-eclampsia contain isosorbide dinitrate. 
 
Table 9: Captopril prescribed at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 65 65.0 65.0 65.0 
Present 35 35.0 35.0 100.0 
Total 100 100.0 100.0  
At the same vicinity in tertiary care centers 35% prescriptions of pre-eclampsia patient 
contain captopril for lowering blood pressure. Captopril is a ACE inhibitor prescribed to 
lower the BP. Its prescribing practice at Islamabad is against the WHO standards. It is 
contraindicated during 2
nd
 and third trimester of pregnancy (Kleinschnitz, Meuth,  S., 
Kieseier & Wiendl, 2007). 
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Table 10: Amino infusion prescribed at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 87 87.0 87.0 87.0 
Present 13 13.0 13.0 100.0 
Total 100 100.0 100.0  
Only 13% patients are taking aminoevil infusion to fulfill the deficiency of protein due to 
proteinurea. 
 
Table 11: Steroids prescribed at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 78 78.0 78.0 78.0 
Present 22 22.0 22.0 100.0 
Total 100 100.0 100.0  
22% of prescriptions at Islamabad contained dexomethasone as important medicine for 
maturation of baby’s lungs. 
 
Table 12: LOPRIN prescribed at ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 76 76.0 76.0 76.0 
Present 24 24.0 24.0 100.0 
Total 100 100.0 100.0  
24% of total prescriptions contain Loprin which is very good at some stages during 
pregnancy but according to age. 
 
Table 13: Iron sulphate prescribed at ISB to pre-eclampsiac 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 98 98.0 98.0 98.0 
Present 2 2.0 2.0 100.0 
Total 100 100.0 100.0  
Only 2% of prescriptions contain iron sulphate to fulfill the iron deficiency and ult imately 
haemoglobin deficiency. 
 
Table 14: Vitamin B12 or folic acid or normal saline prescribed at ISB to pre-eclampsiac 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 90 90.0 90.0 90.0 
Vitamin 6 6.0 6.0 96.0 
Normal saline 4 4.0 4.0 100.0 
Total 100 100.0 100.0  
 
6% of prescriptions contain vitamin B12 in them to fulfill the folic acid deficiency. Similarly 
4% prescriptions contain normal sline drips. However some research says that to a pre-
eclampsiac patient at ward a normal saline iv should be compulsory part of prescription. 
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Table 15: What is STG for pre-eclampsia by WHO in ISB 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
They Do not Know 6 6.0 6.0 6.0 
They Know 26 26.0 26.0 32.0 
gynecologist not found 68 68.0 68.0 100.0 
Total 100 100.0 100.0  
 
In the tertiary care centers of Islamabad the knowledge of the physician about standard 
treatment given by WHO was only 6%. 26% of the physicians said that they do not know 
what WHO recommends for pre-eclampsia. Some of them said that they follow RCOG 
(Royal College of Obstetrics and Gynecology) recommendations and their notebooks are in 
their syllabi. 
 
Table 16: Frequency Data for Abbottabad (Through SPSS 17) 
 
Age of patient 
at AMC 
Gestational age of 
patient at AMC 
Magnesium sulphate 
prescribed or delivery 
advised at AMC 
Methyl dopa 
prescribed at 
AMC 
Nifidipine 
prescribed 
at AMC 
Missing 0 0 0 0 0 
Valid 100 100 100 100 100 
 Frusemide 
prescribed at 
AMC 
ISDN prescribed at 
AMC 
Captopril prescribed at 
AMC 
Amino infusion 
prescribed at 
AMC 
Steroid 
prescribed 
at AMC 
Missing 0 0 0 0 0 
Valid 100 100 100 100 100 
 Aspirin 
prescribed at 
AMC 
Iron sulphate 
prescribed at AMC 
Vitamin B12 or folic acid 
or normal saline 
prescribed at AMC to 
preeclampsiac 
What is STG for 
pre-eclampsia by 
WHO in AMC 
 
Missing 0 0 0 0 0 
Valid 100 100 100 100 100 
A sample of 100 was taken from Abbottabad for each variable including the prescription 
sample for standard drug advice check. Physician knowledge assessment includes 
questionnaires as tools. 
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Table 17: Age of patient at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
20 4 4.0 4.0 4.0 
21 2 2.0 2.0 6.0 
22 1 1.0 1.0 7.0 
23 1 1.0 1.0 8.0 
24 1 1.0 1.0 9.0 
25 9 9.0 9.0 18.0 
26 8 8.0 8.0 26.0 
27 6 6.0 6.0 32.0 
28 2 2.0 2.0 34.0 
29 6 6.0 6.0 40.0 
30 13 13.0 13.0 53.0 
31 3 3.0 3.0 56.0 
32 5 5.0 5.0 61.0 
33 3 3.0 3.0 64.0 
34 3 3.0 3.0 67.0 
35 7 7.0 7.0 74.0 
36 1 1.0 1.0 75.0 
37 3 3.0 3.0 78.0 
38 3 3.0 3.0 81.0 
39 8 8.0 8.0 89.0 
40 5 5.0 5.0 94.0 
41 3 3.0 3.0 97.0 
42 3 3.0 3.0 100.0 
Total 100 100.0 100.0  
The age frequency chart from Islamabad shows that most pre-eclampsia pregnant women are 
from the age group of 25years -30years. The age group highly suffering is 30years of age 
with 13% cases found. 
 
Table 18: Gestational age of patient at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
1 7 7.0 7.0 7.0 
2 6 6.0 6.0 13.0 
3 87 87.0 87.0 100.0 
Total 100 100.0 100.0  
According to the Abbottabad data the gestational age in which pre-eclampsia occurs 87% is 
3
rd
 trimester which is according to the standard studies. As pre-eclampsia occurs mostly in 
32
nd
 week of the pregnancy. (11) 
 
Table 19: Magnesium sulphate prescribed or delivery advised at AMC   
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
STG absent 3 3.0 3.0 3.0 
magnesium sulphate present 93 93.0 93.0 96.0 
delivery 4 4.0 4.0 100.0 
Total 100 100.0 100.0  
This data from Abbottabad clearly depicts that the WHO recommended standard for pre-
eclampsia is present in only 93% of prescriptions. In only 3% of prescriptions it is absent. On 
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the other hand 4% are the delivery cases in pre-eclampsia which is more ideal as treatment as 
proposed by studies. (4) 
 
Table 20: Methyl dopa prescribed at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 2 2.0 2.0 2.0 
Present 98 98.0 98.0 100.0 
Total 100 100.0 100.0  
The trend of prescribing methyl dopa is 98% which is more than MgSO4. But still there will 
b reasons behind for only 5% more prescribing trend of this medicine. Obviously criterion 
changes from patient to patient. 
 
Table 21: Nifidipine prescribed at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 99 99.0 99.0 99.0 
Present 1 1.0 1.0 100.0 
Total 100 100.0 100.0  
Nifidipine is present in only 1 % of prescriptions which shows neglible prescribing trend for 
this medicine at AMC. 
 
Table 22: Frusemide prescribed at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid Absent 100 100.0 100.0 100.0 
No prescriptions frusemide. Which shows that trend of prescribing this medicine during pre-
eclampsia is nil. This is at standard because frusemide is a diuretic strongly contraindicated in 
pregnancy (Bilal, Mir, Mahmood and Amin, 2010). It causes hyperkaliemia, renal 
impairment and hypovolemia which is not tolerable in pre-eclampsia. 
 
Table 23: ISDN prescribed at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 3 3.0 3.0 3.0 
Present 97 97.0 97.0 100.0 
Total 100 100.0 100.0  
 
At Abbottabad 97% of prescriptions for pre-eclampsia contains isosorbide dinitrate. It is a 
vasodilator and blood pressure lowering drug but at the mean time it is pregnancy risk factor 
C drug. So it should be tried to prescribe less. Furthermore its prescription in pre-eclampsia at 
AMC shows that it is last choice to save mother life by lowering blood pressure and taking 
baby life as 2
nd
 priority. 
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Table 24: Captopril prescribed at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid Absent 100 100.0 100.0 100.0 
At the same vicinity in tertiary care centers no prescription of pre-eclampsia patient contains 
captopril for lowering blood pressure.  
 
Table 25: Amino infusion prescribed at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid Absent 100 100.0 100.0 100.0 
Amino infusions were not the part of the prescriptions at AMC. 
 
Table 26: Steroid prescribed at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid Absent 100 100.0 100.0 100.0 
Dexomethasone is not the part of the prescription at AMC. 
 
Table 27: LOPRIN prescribed at AMC 
  Frequency Percent Valid Percent Cumulative Percent 
Valid Absent 100 100.0 100.0 100.0 
Loprin is not the part of the prescription at AMC. 
 
Table 28: Iron sulphate prescribed at AMC  
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
Absent 99 99.0 99.0 99.0 
Present 1 1.0 1.0 100.0 
Total 100 100.0 100.0  
At AMC only 1% of prescriptions contain iron sulphate supplements. 
 
Table 29: Vitamin B12 or folic acid or normal saline prescribed at AMC to pre-eclampsiac 
  Frequency Percent Valid Percent Cumulative Percent 
Valid Absent 100 100.0 100.0 100.0 
No prescription showed presence of vitamin B12 or normal saline drip addition. 
 
Table 30: What is STG for pre-eclampsia by WHO in AMC 
Only 4% physicians know the WHO guidelines for pre-eclampsia.  
 
 
 
  Frequency Percent Valid Percent Cumulative Percent 
Valid 
They Do not Know 2 2.0 2.0 2.0 
They Know 4 4.0 4.0 6.0 
gynecologist not found 94 94.0 94.0 100.0 
Total 100 100.0 100.0  
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CROSSTABULATION ANALYSIS 
Table 1.1 
Case Processing Summary 
 Cases 
 Valid Missing Total 
Magnesium sulphate prescribed or 
delivery advised at ISB * Magnesium 
sulphate prescribed or delivery advised at 
AMC * Gestational age of patient at ISB 
N Percent N Percent N Percent 
100 94.3% 6 5.7% 106 100.0% 
Magnesium sulphate prescribed or 
delivery advised at ISB * Magnesium 
sulphate prescribed or delivery advised at 
AMC * Gestational age of patient at AMC 
100 94.3% 6 5.7% 106 100.0% 
 
A sample of 100 prescriptions was taken each from Islamabad and Abbottabad. Taking into 
account the standard treatment guidelines of WHO the presence of magnesium sulphate as 
first choice medicine was detected. A cross tabulation test was applied among the two city’s 
tertiary care centers to judge which city is more following the standards proposed by WHO. 
 
If we keep the gestational age of patient constant at Islamabad sector and make a comparison 
between the standard prescriptions for pre-eclampsia patient, following facts come out. 
 
2
nd
 GA Period 
1. In the second gestational stage Magnesium sulphate is present in 7 prescriptions at ISB 
and it is present in 11 prescriptions at ATD. Thus Abbottabad is more near to the 
standard. 
1. Magnesium sulphate prescribed or delivery advised at ISB * Magnesium sulphate prescribed or delivery 
advised at AMC * Gestational age of patient at ISB Cross tabulation. 
count      
Gestational age of patient at ISB 
Magnesium sulphate prescribed or 
delivery advised at AMC 
Total 
STG absent 
magnesium 
sulphate 
present 
delivery 
2 
Magnesium sulphate 
prescribed or delivery 
advised at ISB 
STG absent 0 5  5 
Magnesium 
sulphate present 
1 6  7 
Total 1 11  12 
3 
Magnesium sulphate 
prescribed or delivery 
advised at ISB 
STG absent 1 46 3 50 
Magnesium 
sulphate present 
0 33 0 33 
Delivery 1 3 1 5 
Total 2 82 4 88 
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2. In the second gestational stage Magnesium sulphate is absent in 5 prescriptions of ISB 
and it is absent in only one prescription at ATD. Thus Islamabad sector is missing the 
standard prescription trend four times more. 
3. There is no delivery case or abortion case in the second gestational stage. 
 
3
rd
 GA Period 
1. In the third GA Magnesium Sulphate is present in 33 prescriptions at Islamabad sector 
and same medicine is present in 82 prescriptions of Abbottabad sector. It clearly reflects 
that Abbottabad sector is very near to STGs introduced by WHO. 
2. In the third GA Magnesium Sulphate is absent in 50 prescriptions of ISB and same 
medicine is absent in just 2 prescriptions of ATD. Thus Abbottabad sector is avoiding the 
standard negligibly and are following the WHO policy more. 
3. There are 5 delivery cases at ISB and 4 delivery cases at ATD. Thus in this case 
Islamabad is one step forward to save the mother life as proposed by the researches. 
 
GRAPH 1 
This graph is drawn keeping gestational at Islamabad constant. The green area shows that 
mostly Magnesium sulphate is prescribed at Abbottabad AMC. The overall maximum women 
suffering from pre-eclampsia are in third trimester.  
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Table 1.2 
 
If we keep the gestational age of patient constant at Abbottabad sector and make a 
comparison between the standard prescriptions for pre-eclampsia patient, following facts 
come out. 
 
1
st
 GA Period 
1. In the 1st GA of pre-eclampsia patient the Magnesium sulphate is present in 2 
prescriptions at ISD and same medicine is present in 3 prescriptions at ATD. 
2. In the 2nd GA of pre-eclampsia patient the Magnesium sulphate is absent in 3 
prescriptions of ISD and same medicine is absent in 2 prescriptions of ATD. 
3. Similarly there are two delivery cases each in ISD and ATD for pre-eclampsia patients. 
 
2
nd
 GA Period 
1. In the 2nd GA of pre-eclampsia patient at ISD there is 1 prescription containing 
Magnesium sulphate and 4 prescriptions contain Magnesium sulphate at ATD. 
2.Magnesium sulphate prescribed or delivery advised at ISB * Magnesium sulphate prescribed or delivery 
advised at AMC * Gestational age of patient at AMC Cross tabulation 
Count      
Gestational age of patient at AMC 
Magnesium sulphate prescribed or delivery 
advised at AMC 
Total 
STG absent 
magnesium 
sulphate 
present 
delivery 
1 
Magnesium sulphate 
prescribed or delivery 
advised at ISB 
STG absent 0 2 1 3 
Magnesium 
sulphate present 
1 1 0 2 
Delivery 1 0 1 2 
Total 2 3 2 7 
2 
Magnesium sulphate 
prescribed or delivery 
advised at ISB 
STG absent 1 2 1 4 
Magnesium 
sulphate present 
0 1 0 1 
Delivery 0 1 0 1 
Total 1 4 1 6 
3 
Magnesium sulphate 
prescribed or delivery 
advised at ISB 
STG absent  47 1 48 
Magnesium 
sulphate present 
 37 0 37 
Delivery  2 0 2 
 Total  86 1 87 
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2. In the 2nd GA of pre-eclampsia patient at ISD there are 4 prescriptions in which there is 
no Magnesium sulphate and 1 prescription at ATD in which magnesium sulphate is 
absent. 
3. There is one delivery prescribed each in ATD and ISD. 
 
3
rd
 GA Period 
1. In the 3rd GA of pre-eclampsia patient at ISD there are 37 prescriptions in which 
Magnesium sulphate is present and 86 prescriptions at ATD in which Magnesium 
sulphate is present. 
2.  In the 3rd GA of pre-eclampsia patient at ISD there are 48 prescriptions in which 
Magnesium sulphate is absent and no prescription at ATD in which Magnesium sulphate 
is absent. 
3.  There are two delivery cases at ISD and one such case at ATD. 
 
Overall the Islamabad sector is prescribing according to the recommendations of WHO only 
45% and Ayub medical complex Abbottabad is prescribing according to the standards 
introduced by WHO for pre-eclampsia patient wit no other ailment is 96%. AMC Abbottabad 
is more near to general standards of World Health Organization. 
 
 
 
GRAPH 1.2 
This graph shows the Magnesium sulphate or delivery prescribing intensity at Islamabad 
versus same treatment prescribing intensity at Abbottabad AMC. The area under the curve 
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shows prescribing intensity of the Standard. The blue box shows such practice in Islamabad 
and the green box shows such practice at AMC Abbottabad. 
 
It is clear from graph that most prescribing practice of Magnesium sulphate is in Abbottabad 
AMC and similarly most cases belong to the third trimester of pregnancy. 
 
DISCUSSION 
World Health Organization puts forward that Magnesium sulphate is the most necessary anti 
convulsant choice during pre-eclampsia to save the patient from entering into eclampsia 
stage. Similarly they further add that provided knee reflux is absent calcium gluconate is 
medicine of choice given every hour during pre-eclampsia. Further more dihydralazine is 
medicine of choice for lowering blood pressure. 
 
Now in this project report I am determined to find out in two major Pakistan’s city’s tertiary 
care centers that how much they comply with these globally accepted standards. The patient 
ailment under consideration is pre-eclampsia during pregnancy with no other disease. 
In my study and research on Islamabad tertiary care centers I found that only 33% of patients 
are receiving Magnesium sulphate and no patient is getting calcium gluconate or 
dihydralazine in its prescription at Pakistan Institute of Medical Sciences. However in the 
same institution the trend of prescribing nifidipine and adalact is much more in the same 
institution. One major reason behind is at PIMS physicians say that we do not follow WHO 
recommendations as these are not in our syllabi and they follow RCOG rules for prescribing 
medicine to the patient with pre-eclampsia. Similarly at SHIFA International they are 
prescribing Magnesium sulphate to 43% of prescriptions plus 10% of delivery or abortion 
cases. So 53% compliance I calculated at this health center. At this hospital the very quick 
trend observed is of poly pharmacy for multivitamins. The doctor’s knowledge is no mater 
there but still they are unaware of STGs proposed by WHO. In the third hospital of Islamabad 
that is federal services hospital, they are prescribing the standard 45.7% plus 5.7% delivery 
cases. There is a great habit of prescribing frusemide and methyl dopa for lowering blood 
pressure. There doctor’s knowledge about WHO standards was valid and they were 
implementing it well but at the mean time they have never studied WHO guidelines for 
standard treatment protocols. Thus in the Islamabad sector there are total of 45% compliance 
with the WHO guidelines with 88% cases of pre-eclampsia in the third trimester. 
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Whereas in Abbottabad AMC they are prescribing 93% Magnesium sulphate and 4% delivery 
cases. Thus their compliance is 97% for prescribing standards with 87% of third trimester 
cases. There was no prescription containing calcium gluconate or dihydralazine. The 
physicians were unaware of the WHO guidelines. There were no charts of WHO guidelines 
in any city’s center. 98% prescriptions contained methyl dopa for lowering blood pressure 
while 97% prescriptions contained isosorbide dinitrate.  
 
Thus if we compare the two cities though all are ignorant of what exactly WHO recommends 
for pre-eclampsia but again according to their seniors advice and experience Abbottabad 
AMC is very much near to the standards. It is proudly said that the women at such settings 
would be definitely less prone to develop eclampsia after pre-eclampsia. It is sadly thought 
question that why in the developing capital city of Pakistan that is Islamabad we are 50% 
away from the standards. Obviously there are some good reasons behind and there some laps 
for such results which are needed to be vanished. 
 
CONCLUSION 
The ultimate conclusion that comes out is that we are far away from the WHO standards and 
the thing to ponder is our main capital city is more devoid of health’s criterion. Though 
thousand of seminars are conducted daily still there is no punch on the right track. 
Consideration is not there where it is needed. Right now its not too late. We should quickly 
reform the deformed condition. Actually the laps are at the top site first. That is the 
government area where they are not struggling to make such WHO guidelines as regular part 
of the physician’s life. Such books should be the part of gynae syllabi those are recommended 
by WHO. The other researches to read and to seek knowledge from seniors experience should 
be a second choice.  
 
At FGSH there is a written dosage form chart on the walls which is a good sign but at the 
mean time FRUSEMIDE is given to pregnant women to lower their blood pressure which is 
severely contraindicated in pregnancy. The practice of prescribing isosorbide dinitrate, 
frusemide and captopril is against the standards and against mother and child health. 
 
RECOMMENDATIONS 
 At the top level of Government World Health Organization’s accepted syllabi should be 
introduced. 
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 The practice routine of taking advice from a pharmacist at each health care setting about 
the STGs should be preferred as pharmacist is the person who is an expert of medicine. 
 Seminar, work shops and counseling programs should be launched regularly.  
 Monthly meetings and education courses for physicians and pharmacists should be 
conducted to inform them of latest practices and researches. 
 Such activities should be done by the government trough electronic media to create 
awareness among the women. 
 Research work in the mean time should be promoted. 
 Prescribing a mother with drugs like frusemide, captopril and ISDN shows that no matter 
baby’s life is in danger; we are neglecting the health and life of a mother as well. 
 
ANNEXATION 
BY WORLD HEALTH ORGANIZATION 
2007 
Treatment Guidelines:- PRE-ECLAMPSIA/ECLAMPSIA SYNDROME  
Management 
Eclampsia 
1. Magnesium sulphate, IV infusion, 4 g in 250 mL dextrose 5% (or sodium chloride solution 
0.9%) at a rate not exceeding 3 mL per minute 
2. Calcium gluconate 10%, IV, 10 mL given slowly at a rate not exceeding 5 mL per minute 
 
This treatment is recommended for 
Imminent eclampsia 
Eclampsia 
Severe pre-eclampsia, particularly in the presence of complications Check knee reflexes, and 
if absent, give calcium gluconate  
3. Dihydralazine, IV, 0.625 mg every half hour until diastolic blood pressure <100 mmHg. 
Diastolic blood pressure ≥120 mg Hg (short term treatment for hypertension) 
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ABBREVIATIONS 
AMC          Ayub Medical Complex 
ATD           Abbottabad (district) 
FGSH         Federal Government Services Hospital 
GA              Gestational age 
HELLP       Hemolysis Elevated Liver enzyme Low Platelet count 
ISDN          Isosorbide Dinitrate 
PIMS          Pakistan Institute of Medical Sciences 
RCOG        Royal College Of Obstetrics And Gynecology 
SIH             Shifa International Hospital 
STGs          Standard Treatment Guidelines 
WHO          World Health Organization 
 
 
 
 
 
